Description

HoloRam® Sindromet

BIOREGULATOR FOR METABOLIC SYNDROME

 

ACTION

HoloRam® Sindromet is a bioregulator to prevent or normalize imbalances in the metabolism of lipids and carbohydrates associated with increased cholesterol, triglycerides and glycemia.

It contributes to the normalization of cholesterol, triglyceride and glycemic levels, as well as helping to

prevent chronic inflammatory and degenerative processes. This hypoglycemic, hypocholesterolemic and antioxidant action can prevent and facilitate the mobilization of visceral and vascular fat deposits, in addition to contributing to the control of oxidative and inflammatory processes, which helps protect the cardiovascular and neurovascular systems.

HoloRam® Sindromet intervenes at key points of the physiological and metabolic regulation of lipids and carbohydrates as well as energy generation.

 

COMPOSITION PER CAPSULE

 

• Group Adaptogens for bioregulation of metabolic syndrome: synergy between berberine and policosanol: berberine dry extract (Berberis aristata DC, Bark, 97% berberine), 200 mg; poli- cosanol, 5 mg.
• Group Antioxidants: Synergy between astaxanthin and resveratrol. Resveratrol from Ja- panese knotweed (Polygonum cuspidatum root, > 98%), 50 mg; astaxanthin powder from Chlorophyta (Haematococcus pluvialis, algae, 5% astaxanthin), 20 mg.
• Group Immunoregulation and systemic metabolic effect: Vitamin D3 (cholecalciferol, 100,000 IU/g), 1.25 µg.
• Group Components with effect on mitochondrial energy production: L-citrulline-DL- malate, 60 mg; magnesium malate (20% magnesium), 50 mg; coenzyme Q10, 10 m; adenosine 5’-monophosphate (AMP), 0.1 mg; nicotinamide adenine dinucleotide, disodium salt (NADH), 0.1 mg.
• Group Amino acids with hepatoprotective effect: L-methionine, 40 mg.
• Group Probiotics. Synergistic effect on metabolic syndrome: mixture of probiotics: Bifi- dobacterium animalis spp lactis LMG 18314, Lactobacillus plantarum LMG 26367, Bifidobacteri- um longum LMG, Lactobacillus acidophilus LMG 8151, Lactobacillus reuteri LMG 9213, Lacto- bacillus gasseri LMG 26661, 100 mg.

 

EXPLANATION

HoloRam® Sindromet is a dietary supplement as a coadjuvant in the global bioregulation of meta- bolic syndrome, which includes diabetes, obesity, hypertension, impaired cholesterol and triglyceride metabolism and insulin resistance.

It contributes to the normalization of glycemia, due to an improvement in insulin resistance, the regu- larization of cholesterol and triglyceride levels, the improvement in energy production and the protec- tion of the cardiovascular system. The synergy of the activation of berberine, policosanol, astaxanthin and resveratrol produces a systemic action that makes HoloRam® Sindromet a one of a kind food supplement. These metabolic restoration functions, as well as their antioxidant properties produce hypoglycemic, hypocholesterolemic and fat reduction effects useful in type II diabetes, obesity, dys- lipidemia and atherogenesis.

 

• Lipid metabolism: It contributes to a decrease in the levels of bad cholesterol and an increase in HDL cholesterol or good cholesterol, and promotes a reduction in Berberine, poli- cosanol and probiotics act at this level: Bifidobacterium longum, Bifidobacterium animalis lactis, Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus plantarum and Lactobacillus gasseri.
• Carbohydrate metabolism: It contributes to the control of insulin resistance and the regulation of blood glucose levels due to berberine, resveratrol and vitamin
• Liver: It acts as a hepatoprotective and activator of lipid metabolism due to berberine and me-
• Cardiovascular level: It impedes lipid deposits in arteries and viscera due to the synergy of

berberine and vitamin D3.

• Cardioprotective effect: Activation of the energy reserve in the heart muscle due to the effect of coenzyme Q10, magnesium malate and citrulline
• Energy level and energy transfer activation: The combination of coenzyme Q10, citrulline malate, NADH and AMP promote electronic transport, energy production and mitochondrial me- tabolism.
• Systemic level: Anti-inflammatory and antioxidant effect from the combination of astaxanthin, resveratrol, coenzyme Q10, NADH and

 

SUGGESTED SYNERGIES

HoloRam® Sindromet can be supplemented with one of the following products, providing a synergis- tic action in specific cases: HoloRam® Cardivas (Bioregulator of the cardiovascular system), Holo- Ram® Cerevitan (Bioregulator for cognitive functions and neurodegenerative process prevention), HoloRam® Reguline-M (Bioregulatory metabolic), HoloRam® Digest (Bioregulator of the digestive system), HoloRam® Detox (Bioregulator of toxin drainage systems), HoloRam ® Enami (Energy Bioregulator).

 

CONTENTS

60 or 180 capsules of 720 mg.

 

HOW TO USE

Take 2 capsules a day, or as directed by a specialist.

 

RECOMMENDED DAILY ALLOWANCE

2 capsules per day.

 

WARNINGS

Food supplement based on plants, amino acids, probiotics, antioxidants, policosanol, vitamin D3 and nucleotides. Food supplements should not be used as a substitute for a varied and balanced diet. Do not exceed the daily dose expressly recommended. Keep out of the reach of small children. Not to be taken by children or pregnant or breastfeeding women.

 

STORAGE

Keep the container tightly closed in a cool, dry place.